scholarly journals Central line bundle including split-septum device and single use prefilled flushing syringes for prevention of port associated bloodstream infections: A cost and resource utilization analysis

2019 ◽  
Author(s):  
Ilker Devrim ◽  
Mustafa T Ozkul ◽  
İlknur Çağlar ◽  
Yeliz Oruç ◽  
Nevbahar Demiray ◽  
...  
Keyword(s):  
Line Bundle ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Bloodstream Infections ◽  
Central Line ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients ◽  
Central Line Bundle

Abstract Background: Central line bundle programs were found to be effective in decreasing central line–associated bloodstream infection rates in pediatric cancer patients with ports. However cost-effectiveness studies of central line bundle programs in pediatric cancer patients are limited and most available data are from intensive care unit or adult studies. Methods: In this 6 years cross-sectional study, comprehensive assessment of total health care costs attributable to CLABSI’s associated with ports between two periods including 3 years of pre-bundle period and bundle period. Results: This cross-sectional study was carried out in the pediatric hematology-oncology ward of Dr. Behçet Uz Children’s Hospital from 1 August November 2011 to 31 July 2017. The CLABSI rates decreased significantly from 8,31 CLABSIs to 3.04 per 1000 central line days ( p <0.0001). In the prebundle period, total attributable costs spent for of patients with CLABSI were $130661,68 and in the bundle period, total attributable costs spent for patients with CLABSI were $116579,05.Within bundle implantation, 71 potential CLABSI were prevented which saved an additional $208977,81. In other words, for one dollar spent for bundle program, $ 6,54 was saved by decreasing the expected CLABSI. Conclusion: our study shows that central line bundles decreases not only the CLABSI rate, but also decreases attributable costs due to CLABSI. Expenses spent for bundle elements, were covered by savings by preventing CLABSI with higher costs

scholarly journals Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: A cost and resource-utilization analysis

2020 ◽  
Author(s):  
Ilker Devrim ◽  
Mustafa Taha Ozkul ◽  
İlknur Çağlar ◽  
Yeliz Oruç ◽  
Nevbahar Demiray ◽  
...  
Keyword(s):  
Line Bundle ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Bloodstream Infections ◽  
Central Line ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients ◽  
Central Line Bundle

Abstract Background: Central line bundle programs were found to be effective in decreasing central line-associated bloodstream infection rates in pediatric cancer patients with ports. However, cost-effectiveness studies of central line bundle programs in pediatric cancer patients are limited, and most available data are from intensive care unit or adult studies.Methods: In this cross-sectional study spanning 6 years, comprehensive assessment of total health care costs attributable to CLABSI's associated with ports between two periods.Results: This cross-sectional study was carried out in the pediatric hematology-oncology ward of Dr. Behçet Uz Children's Hospital from 1 August November 2011 to 31 July 2017. The CLABSI rates decreased significantly from 8.31 CLABSIs to 3.04 per 1000 central line days (p<0.001). In the pre-bundle period, total attributable costs spent for of patients with CLABSI were $130661, and in the bundle period, total attributable costs spent for patients with CLABSI were $116579. Within bundle implantation, 71 potential CLABSI were prevented, which saved an additional $208977. Conclusion: Our study shows that central line bundles decreases not only the CLABSI rate but also decreases attributable costs due to CLABSI. Expenses spent for bundle elements, were covered by savings by preventing CLABSI with higher costs

scholarly journals Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: A cost and resource-utilization analysis

2020 ◽  
Author(s):  
Ilker Devrim ◽  
Mustafa Taha Ozkul ◽  
İlknur Çağlar ◽  
Yeliz Oruç ◽  
Nevbahar Demiray ◽  
...  
Keyword(s):  
Line Bundle ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Bloodstream Infections ◽  
Central Line ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients ◽  
Central Line Bundle

Abstract Background: Central line bundle programs were found to be effective in decreasing central line-associated bloodstream infection rates in pediatric cancer patients with ports. However, cost-effectiveness studies of central line bundle programs in pediatric cancer patients are limited, and most available data are from intensive care unit or adult studies.Methods: In this cross-sectional study spanning 6 years, comprehensive assessment of total health care costs attributable to CLABSI's associated with ports between two periods.Results: This cross-sectional study was carried out in the pediatric hematology-oncology ward of Dr. Behçet Uz Children's Hospital from 1 August November 2011 to 31 July 2017. The CLABSI rates decreased significantly from 8.31 CLABSIs to 3.04 per 1000 central line days (p<0.001). In the pre-bundle period, total attributable costs spent for of patients with CLABSI were $130661, and in the bundle period, total attributable costs spent for patients with CLABSI were $116579. Within bundle implantation, 71 potential CLABSI were prevented, which saved an additional $208977. Conclusion: Our study shows that central line bundles decreases not only the CLABSI rate but also decreases attributable costs due to CLABSI. Expenses spent for bundle elements, were covered by savings by preventing CLABSI with higher costs

scholarly journals Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: A cost and resource-utilization analysis

2020 ◽  
Author(s):  
Ilker Devrim ◽  
Mustafa T Ozkul ◽  
İlknur Çağlar ◽  
Yeliz Oruç ◽  
Nevbahar Demiray ◽  
...  
Keyword(s):  
Line Bundle ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Bloodstream Infections ◽  
Central Line ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients ◽  
Central Line Bundle

Abstract Background: Central line bundle programs were found to be effective in decreasing central line-associated bloodstream infection rates in pediatric cancer patients with ports. However, cost-effectiveness studies of central line bundle programs in pediatric cancer patients are limited, and most available data are from intensive care unit or adult studies. Methods: In this cross-sectional study spanning 6 years, comprehensive assessment of total health care costs attributable to CLABSI's associated with ports between two periods. Results: This cross-sectional study was carried out in the pediatric hematology-oncology ward of Dr. Behçet Uz Children's Hospital from 1 August 2011 to 31 July 2017. The CLABSI rates decreased significantly from 8.31 CLABSIs to 3.04 per 1000 central line days (p<0.001). In the prebundle period, total attributable costs spent for of patients with CLABSI were $130661, and in the bundle period, total attributable costs spent for patients with CLABSI were $116579. Within bundle implantation, 71 potential CLABSI were prevented, which saved an additional $208977. Conclusion: Our study shows that central line bundles decreases not only the CLABSI rate but also decreases attributable costs due to CLABSI. Expenses spent for bundle elements, were covered by savings by preventing CLABSI with higher costs

scholarly journals Central line bundle including split-septum device and single-use prefilled flushing syringes for prevention of port associated bloodstream infections:A cost and resource utilization analysis

2020 ◽  
Author(s):  
Ilker Devrim ◽  
Mustafa T Ozkul ◽  
İlknur Çağlar ◽  
Yeliz Oruç ◽  
Nevbahar Demiray ◽  
...  
Keyword(s):  
Line Bundle ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Central Line ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Hematology ◽  
Pediatric Cancer Patients ◽  
Central Line Bundle

Abstract Background: Central line bundle programs were found to be effective in decreasing central line-associated bloodstream infection rates in pediatric cancer patients with ports. However, cost-effectiveness studies of central line bundle programs in pediatric cancer patients are limited, and most available data are from intensive care unit or adult studies. Methods: In this six years cross-sectional study, comprehensive assessment of total health care costs attributable to CLABSI's associated with ports between two periods. Results: This cross-sectional study was carried out in the pediatric hematology-oncology ward of Dr. Behçet Uz Children's Hospital from 1 August November 2011 to 31 July 2017. The CLABSI rates decreased significantly from 8.31 CLABSIs to 3.04 per 1000 central line days (p<0.001). In the prebundle period, total attributable costs spent for of patients with CLABSI were $130661, and in the bundle period, total attributable costs spent for patients with CLABSI were $116579. Within bundle implantation, 71 potential CLABSI were prevented, which saved an additional $208977. Conclusion: Our study shows that central line bundles decreases not only the CLABSI rate but also decreases attributable costs due to CLABSI. Expenses spent for bundle elements, were covered by savings by preventing CLABSI with higher costs

scholarly journals A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients

2016 ◽  
Vol 32 (3) ◽  
pp. 475-483 ◽  
Author(s):  
Jin-Shei Lai ◽  
Tracy Haertling ◽  
Joanna Weinstein ◽  
Alfred W. Rademaker ◽  
Stewart Goldman
Keyword(s):  
Cancer Patients ◽  
Pediatric Cancer ◽  
Cross Sectional Study ◽  
Carnitine Deficiency ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients

scholarly journals The Contribution of Motor Changes to Oral Mucositis in Pediatric Cancer Patients: A Cross-Sectional Study

2019 ◽  
Vol 16 (18) ◽  
pp. 3395
Author(s):  
Nyellisonn N. N. Lucena ◽  
Lecidamia C. L. Damascena ◽  
Isabella L. A. Ribeiro ◽  
Luiz M. A. Lima-Filho ◽  
Ana Maria G. Valença
Keyword(s):  
Children And Adolescents ◽  
Cancer Patients ◽  
Oral Mucositis ◽  
Pediatric Cancer ◽  
Body Position ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Pediatric Cancer Patients ◽  
Antineoplastic Treatment

This study aimed to investigate the contribution of motor changes to oral mucositis in children and adolescents with cancer undergoing antineoplastic treatment in a referral hospital. This was an observational, cross-sectional study with 70 patients aged 2 to 19 years, diagnosed with any type of cancer and treated in a pediatric hospital cancer ward from April to September 2017. A questionnaire related to the patients’ socioeconomic and clinical conditions was used, followed by the Oral Assessment Guide and selected domains of the activity and participation section of the International Classification of Functioning, Disability, and Health tool. The data were collected by previously calibrated examiners (kappa index > 0.75) and analyzed using descriptive statistics and logistic regression (α = 5%). Children and adolescents aged 7 to 10 years were more likely to develop oral mucositis (OR: 3.62). In addition, individuals who had severe difficulty in maintaining a body position (OR: 14.45) and walking (OR: 25.42), and those diagnosed with hematologic cancers (OR: 6.40) were more likely to develop oral mucositis during antineoplastic treatment. Within the limitations of this study, it is concluded that motor changes may contribute to the occurrence of oral mucositis in pediatric cancer patients.

Central line bundle for prevention of central line–associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients

2018 ◽  
Vol 19 (4) ◽  
pp. 358-365 ◽  
Author(s):  
İlker Devrim ◽  
Yeliz Oruç ◽  
Bengü Demirağ ◽  
Ahu Kara ◽  
Mine Düzgöl ◽  
...  
Keyword(s):  
Line Bundle ◽  
Bloodstream Infection ◽  
Removal Rate ◽  
Bloodstream Infections ◽  
Venous Access ◽  
Central Line ◽  
Pediatric Cancer Patients ◽  
Single Use ◽  
Venous Access Devices ◽  
Central Line Bundle

Objective: The clinical impact of central line bundle programs for central line–associated bloodstream infections has been well demonstrated in intensive care units. However, the experience of central line bundle programs in totally implantable venous access devices (ports) in pediatric-hematology patients was limited. Methods: A retrospective study was designed to compare and evaluate the clinical impact of implementing a central line bundle for a 2-year 5-month period, including 10 months of prebundle period, 11 months of central line bundle (that includes needleless split-septum devices), and finally 8 months of central line bundle period in which single-use prefilled flushing devices were added to the previous central line bundle. Results: During the prebundle period, the rate of 14.5 central line–associated bloodstream infections per 1000 CL-days had decreased to 5.49 CLABSIs per 1000 CL-days in the first bundle period. The incidence rate ratio with these two groups was 0.379, indicating a relative risk reduction of 62% ( p = 0.005). By the addition of single-use prefilled flushing devices to the first bundle program, the central line–associated bloodstream infection rate decreased to 2.63 per 1000 CL-days. Port removal rate due to central line–associated bloodstream infections was 0.46 per 1000 catheter days in the bundle period, which was significantly lower than in the prebundle period in which port removal rate was 4.5 per 1000 catheter days ( p < 0.001). Conclusion: Central line bundle programs were found to be effective in decreasing central line–associated bloodstream infection rates, improving patients’ quality of life by preventing ports removal due in pediatric cancer patients.

Sign in / Sign up

Export Citation Format

Share Document